
Cerebrospinal Fluid Yields New Insights and Targets for Alzheimer's Treatment
Researchers at Washington University have identified 38 proteins in cerebrospinal fluid linked to Alzheimer's disease, with 15 being potential drug targets. This study highlights the importance of human-derived samples in understanding neurodegeneration and offers new therapeutic avenues. The findings, published in Nature Genetics, demonstrate the power of proteomic analysis in mapping disease-related proteins and genetic pathways.







